Brief: Odonate Therapeutics Announces Financial Results For The Three Months Ended March 31, 2019
25/04/2019 14:20
April 25 (Reuters) - Odonate Therapeutics Inc ODT.O :
* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE
THREE
MONTHS ENDED MARCH 31, 2019
* QUARTERLY LOSS PER SHARE $1.16
* AS OF MARCH 31, 2019, ODONATE HAD $112.1 MILLION IN CASH,
COMPARED TO $139.1 MILLION AS OF DECEMBER 31, 2018
Source text for Eikon: ID:nBw31kXNLa
Further company coverage: ODT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Odonate
See all newsBrief: Odonate Announces Expected Delisting Of Its Stock
Brief: Odonate Therapeutics Announces Planned Return Of Capital To Stockholders Through Share Repurchase Plan
Brief: Odonate Therapeutics Announces Quarterly Loss Per Share Of $0.58
Odonate Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Odonate Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview